Literature DB >> 8822536

Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone.

R D Myers1, M F Lankford.   

Abstract

The selectively bred high alcohol drinking (HAD) line of rat is considered as a potential model of one type of alcoholism. The purpose of the present experiments was to compare the efficacy of two drugs on the volitional drinking of the HAD rats: the 5-HT2A receptor antagonist, amperozide, and a nonselective antagonist of opiate receptors, naltrexone. To determine the pattern of alcohol drinking of the HAD rats, a standard preference test was used in which water was offered with alcohol increased in concentrations from 3% to 30% over 11 days. The maximally preferred concentration of alcohol of each rat was offered for 4 days and ranged from 7% to 20% with a mean intake of 6.9 g/kg per day. Initially, 1.0 mg/kg amperozide, 2.5 mg/kg naltrexone, or the saline vehicle were injected twice daily for 4 days at 1600 and 2200 hours. Secondly, 2.0 mg/kg amperozide, 5.0 mg/kg naltrexone, or the saline vehicle were administered also for 4 days. After the drug sequences, alcohol preference tests continued for another 4 days. Whereas the saline vehicle was without effect on drinking, the administration of either drug caused a significant dose-dependent reduction in the daily intake of alcohol by the HAD rats in terms of absolute g/kg and proportion of alcohol to water consumed. A comparison of the drinking response to the higher doses of the two drugs showed that amperozide was more efficacious in suppressing alcohol intake than naltrexone. Niether amperozide nor naltrexone exerted any significant effects on food and water intakes or on body weight. These results support the concept of a functional link in the brain between the serotonergic and opioidergic systems postulated to underlie, in part, the aberrant drinking of alcohol. A marked dissociation between the temporal patterns of drinking after naltrexone and amperozide treatment suggests that the opiate receptors mediate the immediate reinforcing effects of alcohol, whereas the more vegetative phenomena underlying addictive properties of alcohol are regulated by 5-HT2A receptors postsynaptic to serotonergic neurons. Finally, the inhibitory actions of both drugs imply that multiple receptor mechanisms within the mesolimbic and other systems in the brain underpin the addictive liability to alcohol.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8822536     DOI: 10.1016/0893-133X(95)00081-N

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  9 in total

1.  Ontogenetic differences in ethanol's motivational properties during infancy.

Authors:  Michael E Nizhnikov; Ricardo Marcos Pautassi; Elena I Varlinskaya; Pouyan Rahmani; Norman E Spear
Journal:  Alcohol       Date:  2012-03-21       Impact factor: 2.405

Review 2.  Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment.

Authors:  Bankole A Johnson
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

3.  Effects of naltrexone on post-abstinence alcohol drinking in C57BL/6NCRL and DBA/2J mice.

Authors:  Arthur Tomie; Idu Azogu; Lei Yu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-03-13       Impact factor: 5.067

Review 4.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

Review 5.  Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.

Authors:  Bankole A Johnson
Journal:  Biochem Pharmacol       Date:  2007-08-09       Impact factor: 5.858

6.  A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.

Authors:  Kyle M Kampman; Helen M Pettinati; Kevin G Lynch; Tom Whittingham; Wayne Macfadden; Charles Dackis; Carlos Tirado; David W Oslin; Thorne Sparkman; Charles P O'Brien
Journal:  J Clin Psychopharmacol       Date:  2007-08       Impact factor: 3.153

7.  Introduction to the special issue "Pharmacotherapies for the treatment of alcohol abuse and dependence" and a summary of patents targeting other neurotransmitter systems.

Authors:  Richard L Bell; Kelle M Franklin; Sheketha R Hauser; Feng C Zhou
Journal:  Recent Pat CNS Drug Discov       Date:  2012-08

8.  Kappa-opioid receptors differentially regulate low and high levels of ethanol intake in female mice.

Authors:  Ashlee Van't Veer; Karen L Smith; Bruce M Cohen; William A Carlezon; Anita J Bechtholt
Journal:  Brain Behav       Date:  2016-07-24       Impact factor: 2.708

9.  Evaluating the Impact of Naltrexone on the Rat Gambling Task to Test Its Predictive Validity for Gambling Disorder.

Authors:  Patricia Di Ciano; Bernard Le Foll
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.